Biopharma

STAT+: How RFK Jr. could revive a dormant task force to...

As health secretary, Kennedy could revive a defunct task force to scrutinize the...

Should weight-loss drugs be given to children?

A battle over how to treat childhood obesity is brewing between those in favour ...

Vertex COO Arbuckle to step down later this year

Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his rol...

Key GOP senators push back against NIH funding cuts

Sens. Bill Cassidy (La.) and Susan Collins (Maine) expressed concern Monday abou...

STAT+: NIH scraps program to diversify the biomedical w...

Applications for a prestigious NIH grant that supports Ph.D. students from margi...

Effect of Behavioral Intervention on Reducing Care Over...

MONDAY, Feb. 10, 2025 -- Clinical decision support (CDS) aimed at reducing over...

Federal judge halts Trump administration cuts to NIH re...

Attorneys general sued the Trump administration to block a NIH decision that wou...

Fierce Biotech Layoff Tracker 2025: Q32 Bio restructure...

As always, if you know of layoffs occurring at a biotech, please reach out to th...

Tasso rolls out new at-home dried blood spot sample col...

Its Tile-T20 cartridge and the wearable Tasso Mini push-button lancet are design...

DNA sequencing shares slide amid 'headwinds' from Trump...

In Monday’s trading, Pacific Biosciences and 10x Genomics each saw their stock p...

Allarity Therapeutics Announces Expansion of Phase 2 Cl...

Boston (February 6, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Compan...

Boehringer’s Nerandomilast Meets Primary Endpoint in Ph...

Ingelheim, Germany, February 10, 2025 - Boehringer Ingelheim announced today th...

Nektar Therapeutics Receives Fast Track Designation for...

SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) ...

Pliant Therapeutics Provides Update on BEACON-IPF, a Ph...

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeuti...

Boehringer widens fibrosis drug's approval path after b...

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibr...

Incyte's JAK cream Opzelura picks up steam as company w...

With Incyte's bread-and-butter Jakafi approaches a 2028 patent cliff, its topica...

STAT+: Mass General Brigham announces largest layoff in...

Mass General Brigham said Monday it will let go of hundreds of employees in the ...

UPDATE: 22 states sue NIH over biomedical research gran...

A new initiative rolled out under President Donald Trump’s administration is cut...

22 states sue to block Trump administration cuts to NIH...

Attorneys general sued the Trump administration to block a NIH decision that wou...

ASA: Mechanical Removal of Clot No Better Than Best Med...

MONDAY, Feb. 10, 2025 -- Endovascular thrombectomy (EVT) does not lead to bette...

Body Weight Cycling Tied to Increased Risk for Renal Ev...

MONDAY, Feb. 10, 2025 -- For individuals with type 1 diabetes, intraindividual ...

Salt Substitution Cuts Risk for Recurrent Stroke

MONDAY, Feb. 10, 2025 -- Salt substitution is safe and reduces the risk for str...

ACP Issues Clinical Guideline for Pharmacologic Prevent...

MONDAY, Feb. 10, 2025 -- In a clinical guideline issued by the American College...

SARS-CoV-2 Infection Linked to More Rapid Plaque Growth...

MONDAY, Feb. 10, 2025 -- Severe acute respiratory syndrome coronavirus 2 (SARS-...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.